The Telecommunications Industry Association supports Food and Drug Administration intentions not to enforce some regulatory controls that apply to medical device data systems (MDDS), which the agency deems to be low risk to patients.  

TIA makes the case in an Aug. 25 letter to the regulatory agency that FDA’s proposed guidance on MDDS will “facilitate greater innovation in the medical device industry” and is consistent with the agency’s stated goals of “taking an appropriately-tailored approach to medical device innovation.”

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access